Cargando…

Qinglong Zhidong Decoction Alleviated Tourette Syndrome in Mice via Modulating the Level of Neurotransmitters and the Composition of Gut Microbiota

Qinglong Zhidong Decoction (QLZDD), a traditional Chinese medicine (TCM) prescription, has been effectively used to alleviate Tourette syndrome (TS) in children. However, the therapeutic mechanism of QLZDD on TS has not been evaluated. The present study aims to elucidate the therapeutic effect and t...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Na, Wu, Xinchen, Yang, Qi, Wang, Dingyue, Wu, Zhao, Wei, Yuanyuan, Cui, Jieqiong, Hong, Li, Xiong, Lei, Qin, Dongdong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8981146/
https://www.ncbi.nlm.nih.gov/pubmed/35392572
http://dx.doi.org/10.3389/fphar.2022.819872
_version_ 1784681540989485056
author Wang, Na
Wu, Xinchen
Yang, Qi
Wang, Dingyue
Wu, Zhao
Wei, Yuanyuan
Cui, Jieqiong
Hong, Li
Xiong, Lei
Qin, Dongdong
author_facet Wang, Na
Wu, Xinchen
Yang, Qi
Wang, Dingyue
Wu, Zhao
Wei, Yuanyuan
Cui, Jieqiong
Hong, Li
Xiong, Lei
Qin, Dongdong
author_sort Wang, Na
collection PubMed
description Qinglong Zhidong Decoction (QLZDD), a traditional Chinese medicine (TCM) prescription, has been effectively used to alleviate Tourette syndrome (TS) in children. However, the therapeutic mechanism of QLZDD on TS has not been evaluated. The present study aims to elucidate the therapeutic effect and the possible therapeutic mechanism of QLZDD on TS in mouse model. A 3,3-iminodipropionitrile (IDPN, 350 mg/kg)-induced-TS mouse model was established. The mice were randomly divided into the control group, the model group, the haloperidol group (14 mg/kg), the low-, middle-, or high-QLZDD-dose groups (6.83 g/kg, 13.65 g/kg, 27.3 g/kg). QLZDD was administrated orally once a day for 4 weeks. The tic-like behavior was recorded weekly. Then, neurotransmitters and neurotransmitter receptors were analyzed by ELISA, immunohistochemistry (IHC), and quantitative reverse transcription PCR in striatum. Further, the alteration to intestinal flora was monitored by 16s rRNA sequencing, and the role of gut microbiota in the alleviation of TS by QLZDD was investigated. QLZDD ameliorated the tic-like behavior, and decreased the level of excitatory neurotransmitters such as Glu and DA and increased the level of the inhibitory neurotransmitter GABA significantly. Moreover, QLZDD significantly blocked the mRNA expression and the protein expression of D1R and D2R in the striatum, while activated the levels of DAT and GABAR. Interestingly, QLZDD mediated the composition of gut microbiota by increasing the abundance of Lactobacillus and Bacteroides but decreasing the abundance of Alloprevotella and Akkermansia. Taken together, QLZDD ameliorated the tic-like behavior in TS mouse, its mechanism of action may be associated with restoring the balance of gut microbiota and neurotransmitters. The study indicated a promising role of QLZDD in alleviating TS and a therapeutic strategy for fighting TS in clinical settings.
format Online
Article
Text
id pubmed-8981146
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-89811462022-04-06 Qinglong Zhidong Decoction Alleviated Tourette Syndrome in Mice via Modulating the Level of Neurotransmitters and the Composition of Gut Microbiota Wang, Na Wu, Xinchen Yang, Qi Wang, Dingyue Wu, Zhao Wei, Yuanyuan Cui, Jieqiong Hong, Li Xiong, Lei Qin, Dongdong Front Pharmacol Pharmacology Qinglong Zhidong Decoction (QLZDD), a traditional Chinese medicine (TCM) prescription, has been effectively used to alleviate Tourette syndrome (TS) in children. However, the therapeutic mechanism of QLZDD on TS has not been evaluated. The present study aims to elucidate the therapeutic effect and the possible therapeutic mechanism of QLZDD on TS in mouse model. A 3,3-iminodipropionitrile (IDPN, 350 mg/kg)-induced-TS mouse model was established. The mice were randomly divided into the control group, the model group, the haloperidol group (14 mg/kg), the low-, middle-, or high-QLZDD-dose groups (6.83 g/kg, 13.65 g/kg, 27.3 g/kg). QLZDD was administrated orally once a day for 4 weeks. The tic-like behavior was recorded weekly. Then, neurotransmitters and neurotransmitter receptors were analyzed by ELISA, immunohistochemistry (IHC), and quantitative reverse transcription PCR in striatum. Further, the alteration to intestinal flora was monitored by 16s rRNA sequencing, and the role of gut microbiota in the alleviation of TS by QLZDD was investigated. QLZDD ameliorated the tic-like behavior, and decreased the level of excitatory neurotransmitters such as Glu and DA and increased the level of the inhibitory neurotransmitter GABA significantly. Moreover, QLZDD significantly blocked the mRNA expression and the protein expression of D1R and D2R in the striatum, while activated the levels of DAT and GABAR. Interestingly, QLZDD mediated the composition of gut microbiota by increasing the abundance of Lactobacillus and Bacteroides but decreasing the abundance of Alloprevotella and Akkermansia. Taken together, QLZDD ameliorated the tic-like behavior in TS mouse, its mechanism of action may be associated with restoring the balance of gut microbiota and neurotransmitters. The study indicated a promising role of QLZDD in alleviating TS and a therapeutic strategy for fighting TS in clinical settings. Frontiers Media S.A. 2022-03-22 /pmc/articles/PMC8981146/ /pubmed/35392572 http://dx.doi.org/10.3389/fphar.2022.819872 Text en Copyright © 2022 Wang, Wu, Yang, Wang, Wu, Wei, Cui, Hong, Xiong and Qin. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Wang, Na
Wu, Xinchen
Yang, Qi
Wang, Dingyue
Wu, Zhao
Wei, Yuanyuan
Cui, Jieqiong
Hong, Li
Xiong, Lei
Qin, Dongdong
Qinglong Zhidong Decoction Alleviated Tourette Syndrome in Mice via Modulating the Level of Neurotransmitters and the Composition of Gut Microbiota
title Qinglong Zhidong Decoction Alleviated Tourette Syndrome in Mice via Modulating the Level of Neurotransmitters and the Composition of Gut Microbiota
title_full Qinglong Zhidong Decoction Alleviated Tourette Syndrome in Mice via Modulating the Level of Neurotransmitters and the Composition of Gut Microbiota
title_fullStr Qinglong Zhidong Decoction Alleviated Tourette Syndrome in Mice via Modulating the Level of Neurotransmitters and the Composition of Gut Microbiota
title_full_unstemmed Qinglong Zhidong Decoction Alleviated Tourette Syndrome in Mice via Modulating the Level of Neurotransmitters and the Composition of Gut Microbiota
title_short Qinglong Zhidong Decoction Alleviated Tourette Syndrome in Mice via Modulating the Level of Neurotransmitters and the Composition of Gut Microbiota
title_sort qinglong zhidong decoction alleviated tourette syndrome in mice via modulating the level of neurotransmitters and the composition of gut microbiota
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8981146/
https://www.ncbi.nlm.nih.gov/pubmed/35392572
http://dx.doi.org/10.3389/fphar.2022.819872
work_keys_str_mv AT wangna qinglongzhidongdecoctionalleviatedtourettesyndromeinmiceviamodulatingthelevelofneurotransmittersandthecompositionofgutmicrobiota
AT wuxinchen qinglongzhidongdecoctionalleviatedtourettesyndromeinmiceviamodulatingthelevelofneurotransmittersandthecompositionofgutmicrobiota
AT yangqi qinglongzhidongdecoctionalleviatedtourettesyndromeinmiceviamodulatingthelevelofneurotransmittersandthecompositionofgutmicrobiota
AT wangdingyue qinglongzhidongdecoctionalleviatedtourettesyndromeinmiceviamodulatingthelevelofneurotransmittersandthecompositionofgutmicrobiota
AT wuzhao qinglongzhidongdecoctionalleviatedtourettesyndromeinmiceviamodulatingthelevelofneurotransmittersandthecompositionofgutmicrobiota
AT weiyuanyuan qinglongzhidongdecoctionalleviatedtourettesyndromeinmiceviamodulatingthelevelofneurotransmittersandthecompositionofgutmicrobiota
AT cuijieqiong qinglongzhidongdecoctionalleviatedtourettesyndromeinmiceviamodulatingthelevelofneurotransmittersandthecompositionofgutmicrobiota
AT hongli qinglongzhidongdecoctionalleviatedtourettesyndromeinmiceviamodulatingthelevelofneurotransmittersandthecompositionofgutmicrobiota
AT xionglei qinglongzhidongdecoctionalleviatedtourettesyndromeinmiceviamodulatingthelevelofneurotransmittersandthecompositionofgutmicrobiota
AT qindongdong qinglongzhidongdecoctionalleviatedtourettesyndromeinmiceviamodulatingthelevelofneurotransmittersandthecompositionofgutmicrobiota